|
Screening test
|
Mean sojourn time (years)
|
---|
|
sensitivity (%)
|
40 to 49
|
50-59
|
---|
Invasive
|
Invasive
|
In-situ
|
NPIS
|
PIS
|
PIBC
|
NPIS
|
PIS
|
PIBC
|
Base case
|
Median1
|
Median
|
3
|
0.175
|
1.825
|
Long MST
|
Median
|
Upper limit2
|
5
|
0.25
|
2.75
|
Short MST
|
Median
|
Lower limit3
|
2
|
0.1
|
1.5
|
High sensitivity
|
100
|
100
|
Median
|
3
|
0.175
|
1.825
|
Low sensitivity
|
Lower limit
|
Median
|
3
|
0.175
|
1.825
|
Low sensitivity, long MST
|
Lower limit
|
Upper limit
|
5
|
0.25
|
2.75
|
High sensitivity, long MST
|
100
|
100
|
Upper limit
|
5
|
0.25
|
2.75
|
- 1,2,3Refers to the median, upper limit, and lower limit of resultsfrom parameter estimation model, respectively. MST, median sojourn time; NPIC,non-progressive in situ; PIBC, preclinical invasive breast cancer; PIS,preclinical progressive in situ.